Related Experiment Video
Updated: Jun 22, 2026

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
Published on: April 15, 2014
Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis
Corinna Trebst1, Ansgar Reising, Jan T Kielstein
1Department of Neurology, Medical School Hannover, Hannover, Germany. trebst.corinna@mh-hannover.de
Background:
Plasma exchange (PE) is well established for conditions such as rapid progressive vasculitis associated with autoantibodies against neutrophil cytoplasmic antigens (ANCA), anti-glomerular basement membrane (GBM) antibody disease, or thrombotic thrombocytopenic purpura (TTP). Also, several neurological disorders, such as acute worsening in myasthenia gravis, Guillan-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP), can successfully be treated with PE. Only small case series have previously shown that PE is also effective in relapses in patients with multiple sclerosis (MS).
Methods:
We report our experiences of PE therapy in a series of 20 patients with 21 steroid unresponsive MS relapses.
Results:
A marked-to-moderate clinical response with clear gain of function in 76% of patients with uni- or bilateral optic neuritis and in 87.5% of patients with relapses other than optic neuritis was observed.
Conclusions:
PE is an effective and well tolerated therapeutic option for steroid-unresponsive MS relapses.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Multiple Sclerosis l: Introduction
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
